Relay Therapeutics Inc Share Price Today: Live Updates & Key Insights
Relay Therapeutics Inc share price today is $9.93, up -0.9%. The stock opened at $10.33 against the previous close of $10, with an intraday high of $10.71 and low of $9.7.
Relay Therapeutics Inc Share Price Chart
Relay Therapeutics Inc
Relay Therapeutics Inc Share Price Performance
Relay Therapeutics Inc Institutional Holdings
Relay Therapeutics Inc Market Status
Relay Therapeutics Inc Fundamentals
Market Cap 1771.17 M
PB Ratio 3.1518
PE Ratio 0.0
Enterprise Value 1265.20 M
Total Assets 621.33 M
Volume 3824089
Relay Therapeutics Inc Company Financials
About Relay Therapeutics Inc & investment objective
Company Information Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGal chaperone for Fabry diseases. It also develops RLY-8161, an oncogene driver that belongs to the RAS family of signaling proteins. In addition, the company develops lirafugratinib (RLY-4008), a receptor tyrosine kinase for the treatment of cancer. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; Elevar Therapeutics, Inc. for the development and commercialization of RLY-4008; and Pfizer Inc. for the development of RLY-2608 in combination with fulvestrant and atirmociclib. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 192
Industry Biotechnology
CEO Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Relay Therapeutics Inc FAQs
What is the share price of Relay Therapeutics Inc today?
The current share price of Relay Therapeutics Inc is $9.93.
Can I buy Relay Therapeutics Inc shares in India?
Yes, Indian investors can buy Relay Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Relay Therapeutics Inc shares in India?
You can easily invest in Relay Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Relay Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Relay Therapeutics Inc.
Can I buy fractional shares of Relay Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Relay Therapeutics Inc?
Relay Therapeutics Inc has a market cap of $1771.17 M.
In which sector does Relay Therapeutics Inc belong?
Relay Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Relay Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Relay Therapeutics Inc?
The PE ratio of Relay Therapeutics Inc is N/A and the PB ratio is 3.15.